NCT00475436View on ClinicalTrials.gov

A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 14, 2007

Primary Completion Date

September 18, 2007

Study Completion Date

September 18, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK573719

Trial Locations (1)

14050

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY